Dresden Glaucoma and Treatment Study (DGTS)

Dresden Glaucoma and Treatment Study: Analysis to Assure the Quality of Follow-up and Therapy of Glaucoma Patients in a Tertiary University Hospital Glaucoma Service.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02959242

Enrollment

10000

Registered

2016-11-09

Start date

2006-01-01

Completion date

2032-12-01

Last updated

2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Glaucoma, Angle-Closure, Glaucoma, Low Tension, Glaucoma, Open-Angle

Keywords

Follow-up intervals, Treatment Efficiency, Laser Therapy, Glaucoma Surgery, Minimal Invasive Glaucoma Surgery (MIGS)

Brief summary

To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.

Detailed description

The aim of the study is to evaluate the quality of follow-up and treatment by means of consecutive data collection and anonymised analysis of all glaucoma patients of a tertiary university hospital glaucoma service. Parameters being analyzed are: Age, sex, refraction, family history, known duration of glaucoma, highest intraocular pressure before treatment, systemic and topical medication, previous ocular surgery. 24h Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph (HRT), glaucoma diagnosis with Scanning-Laser-Polarimetry (GDx), optical coherence tomography (OCT), Pentacam, Ocular Response Analyzer (ORA), Corvis ST (Corneal Visualization with the Scheimpflug Technology), perimetry

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* manifest glaucoma, ocular Hypertension, glaucoma suspect

Exclusion criteria

* under 18 years of age, corneal diseases

Design outcomes

Primary

Measure	Time frame	Description
Follow-up intervals	20 years	To find the best follow-up intervals for glaucoma patients.

Secondary

Measure	Time frame	Description
Assessment of treatment quality	20 years	What is the best treatment option for the individual patient?
Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy	20 years	Diurnal intraocular pressure, best corrected visual acuity, visual fields
Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy of glaucoma surgery	20 years	Diurnal intraocular pressure, best corrected visual acuity, visual fields

Countries

Germany

Contacts

CONTACTKarin R Pillunat, MD

karin.pillunat@uniklinikum-dresden.de+49 351 458 3274

CONTACTLutz E Pillunat, MD, PhD

lutze.pillunat@uniklinikum-dresden.de+49 351 458 3381

STUDY_DIRECTORLutz E Pillunat, MD, PhD

Medical faculty of the Technical University of Dresden, Germany

Outcome results